SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PureTech Health plc(15.9%),PureTech Health LLC(15.9%)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SC TO-I: Issuer tender offer statement
20-F: Registration statement / Annual report / Transition report
6-K: Report of foreign private issuer (related to financial reporting)
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | SC TO-C: Written communication relating to an issuer or third party tender offer
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 6-K: Report of foreign private issuer (related to financial reporting)
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invesco Ltd.(23.7%)
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 6-K: Report of foreign private issuer (related to financial reporting)
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Puretech Health | 4: Statement of changes in beneficial ownership of securities-10% Owner PureTech Health plc
Puretech Health | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data